In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR3355)
- 31 October 1995
- journal article
- research article
- Published by Elsevier in Tubercle and Lung Disease
- Vol. 76 (5) , 377-380
- https://doi.org/10.1016/0962-8479(95)90001-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Phase I Study of Levofloxacin, (S)-(-)-Ofloxacin.Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics, 1992
- Comparative in vitro and in vivo activity of fleroxacin and ofloxacin against various mycobacteriaTubercle, 1991
- In-vitro and in-vivo activity of DR-3355, an optically active isomer of ofloxacinJournal of Antimicrobial Chemotherapy, 1990
- Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in miceAntimicrobial Agents and Chemotherapy, 1990
- In vitro Antibacterial Activity of DR-3355, the S-(––)-Isomer of OfloxacinChemotherapy, 1990
- Comparative in vitro and in vivo activity of rifabutin and rifampicin against mycobacterium avium complexTubercle, 1988
- In vitro activity of DR-3355, an optically active ofloxacinAntimicrobial Agents and Chemotherapy, 1988
- Inhibition of DNA gyrase by optically active ofloxacinAntimicrobial Agents and Chemotherapy, 1987
- Synthesis and antibacterial activities of optically active ofloxacinAntimicrobial Agents and Chemotherapy, 1986